Genclis Overview

  • Year Founded
  • 2004

Year Founded

  • Status
  • Private

  • Employees
  • 22

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Financing Rounds
  • 7

Genclis General Information

Description

Operator of a biotechnology company intended to discover, develop and commercialize diagnostic tests for cancer and allergy. The company's core competencies include analysis and measurement of low-intensity signals of RNA-DNA differences (RDDs) which helps in the prediction of cancer severity, enabling healthcare institutions and professionals to facilitate the decision-making process and allow the personalization of treatments, while increasing their efficiency and reducing costs.

Contact Information

Website
www.genclis.com
Ownership Status
Privately Held (backing)
Financing Status
Formerly PE-Backed
Corporate Office
  • 15 Rue du Bois de la Champelle
  • 54500 Vandœuvre-lès-Nancy
  • France
+33 03
Primary Industry
Biotechnology
Other Industries
Discovery Tools (Healthcare)
Vertical(s)
Corporate Office
  • 15 Rue du Bois de la Champelle
  • 54500 Vandœuvre-lès-Nancy
  • France
+33 03

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Genclis Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Genclis‘s full profile, request access.

Request a free trial

Genclis Patents

Genclis Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2023104904-A2 The sars-cov-2 and variants use two independent cell receptors to replicate Inactive 08-Dec-2021
WO-2023104904-A3 The sars-cov-2 and variants use two independent cell receptors to replicate Inactive 08-Dec-2021
WO-2023057398-A1 Transcription infidelity derived and enhanced chimeric immunogens and uses thereof Inactive 05-Oct-2021
EP-4162948-A1 Transcription infidelity derived chimeric immunogens and uses thereof Inactive 05-Oct-2021
JP-6899890-B2 Molecular origin of allergies Inactive 18-Mar-2016 A23C9/1465
To view Genclis’s complete patent history, request access »

Genclis Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Genclis FAQs

  • When was Genclis founded?

    Genclis was founded in 2004.

  • Where is Genclis headquartered?

    Genclis is headquartered in Vandœuvre-lès-Nancy, France.

  • What is the size of Genclis?

    Genclis has 22 total employees.

  • What industry is Genclis in?

    Genclis’s primary industry is Biotechnology.

  • Is Genclis a private or public company?

    Genclis is a Private company.

  • What is Genclis’s current revenue?

    The current revenue for Genclis is .

  • How much funding has Genclis raised over time?

    Genclis has raised $24.9M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process